Cannabist Co Holdings Inc. Files 8-K on Leadership Changes
Ticker: CBSTF · Form: 8-K · Filed: Nov 18, 2025 · CIK: 1776738
| Field | Detail |
|---|---|
| Company | Cannabist Co Holdings Inc. (CBSTF) |
| Form Type | 8-K |
| Filed Date | Nov 18, 2025 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $15,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, executive-compensation, board-of-directors
TL;DR
Cannabist Co Holdings Inc. is changing up its board and exec pay. Keep an eye on this.
AI Summary
On November 17, 2025, The Cannabist Company Holdings Inc. filed an 8-K report detailing changes in its board of directors and executive compensation arrangements. The filing indicates a shift in leadership and potential adjustments to how key personnel are compensated.
Why It Matters
Changes in a company's board and executive compensation can signal strategic shifts or internal restructuring, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in board composition and executive compensation can indicate underlying issues or strategic realignments that may affect the company's future stability and performance.
Key Players & Entities
- The Cannabist Company Holdings Inc. (company) — Registrant
- Columbia Care Inc. (company) — Former company name
FAQ
What specific changes were made to the board of directors?
The filing indicates "Departure of Directors or Certain Officers; Election of Directors" as an item of information, suggesting changes to the board composition.
What is the nature of the compensatory arrangements being reported?
The filing lists "Compensatory Arrangements of Certain Officers" as an item of information, indicating updates or new details regarding executive compensation.
When was the earliest event reported in this filing?
The earliest event reported was on November 17, 2025.
What was the former name of The Cannabist Company Holdings Inc.?
The former name of the company was Columbia Care Inc.
What is the principal executive office address for The Cannabist Company Holdings Inc.?
The principal executive offices are located at 321 Billerica Road, Chelmsford, Massachusetts 01824.
Filing Stats: 806 words · 3 min read · ~3 pages · Grade level 13.2 · Accepted 2025-11-17 18:12:43
Key Financial Figures
- $15,000 — eement, the Company will pay Mr. Watson $15,000 per month. In addition, Mr. Watson will
Filing Documents
- cbstf-20251117.htm (8-K) — 24KB
- 0001776738-25-000057.txt ( ) — 130KB
- cbstf-20251117.xsd (EX-101.SCH) — 2KB
- cbstf-20251117_lab.xml (EX-101.LAB) — 20KB
- cbstf-20251117_pre.xml (EX-101.PRE) — 11KB
- cbstf-20251117_htm.xml (XML) — 2KB
02. Departure of Directors or Certain Officers; Election of Directors;
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On November 15, 2025, Derek Watson, the Chief Financial Officer ("CFO") of The Cannabist Company Holdings Inc. (the "Company"), resigned his employment position with the Company, effective November 15, 2025, and entered into a CFO Consulting Agreement, dated November 15, 2025 (the "Watson CFO Consulting Agreement" or the "Engagement Agreement") with the Company, as further described below. Mr. Watson's transition from employee to non-employee consultant is not a result of any disagreement with the Company or any matter relating to its financial statements, internal controls, operations, policies or practices. Through the Watson CFO Consulting Agreement, the Company engaged Mr. Watson to continue to serve as the Chief Financial Officer of the Company in a non-employee consultant capacity, allocating a minority of his working time to the Company. Mr. Watson joined the Company as an employee in 2022 as the Chief Financial Officer. Pursuant to the Engagement Agreement, the Company will pay Mr. Watson $15,000 per month. In addition, Mr. Watson will be eligible to participate in the Company's discretionary executive bonus plan for 2025 based on a performance period from January 1, 2025, to November 15, 2025 (the "Bonus Performance Term"), subject to the terms of the Company's discretionary executive bonus plan and based upon the achievement of corporate and individual goals. The initial term of the Engagement Agreement is from November 16, 2025, to May 15, 2026, and may continue until modified or terminated on its terms. The Engagement Agreement can be terminated (1) for cause by Cannabist by providing written notice of its intention to terminate the Agreement for cause or (2) at any time for any reason by Mr. Watson provided that written notice is sent at least (2) months prior to the effective date of terminat